Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder

Treprostinil palmitil (TP), a prodrug of treprostinil, is being developed as an inhalation powder (TPIP) for the treatment of patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension due to interstitial lung disease (PH-ILD). In ongoing human clinical trials, TPIP is administer...

Full description

Bibliographic Details
Main Authors: Helena Gauani, Thomas Baker, Zhili Li, Vladimir S. Malinin, Walter R. Perkins, Eugene J. Sullivan, David Cipolla
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceutics
Subjects:
device performance
dry powder inhaler (DPI)
fine particle dose (FPD)
aerosol delivery
inhalation
treprostinil palmitil (TP)
Online Access:https://www.mdpi.com/1999-4923/15/3/934

Internet

https://www.mdpi.com/1999-4923/15/3/934

Similar Items